Developer docs
API playgroundTry for free, no card

Search company profiles

Ariti

Full company profile

uuid0028rvs

Namestring
Ariti
Legal namestring
ΑΡΗΤΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΚΑΙ ΙΑΤΡΙΚΩΝ ΠΡΟΪΟΝΤΩΝ
Websiteurl
ariti.gr
Company typeenum
Private
Founded yearint
1985
Descriptiontext

Ariti is a Greek pharmaceutical and medical technology distribution company founded in 1985, headquartered in Greece and operating across both Greece and Cyprus. The company distributes pharmaceuticals across oncology, urology, central nervous system, and rare diseases therapeutic areas, alongside medical devices spanning dialysis machines, catheters, orthopaedic implants, and surgical products. Its core business model rests on long-standing exclusive distribution agreements with international manufacturers, combined with vertical integration into clinical services through 10 private dialysis units across Greece.

The company operates through distinct divisions covering pharmaceuticals, medical devices, and rare diseases, the last of which was established as a dedicated business unit in 2019 to commercialize orphan drugs. Revenue mechanics are anchored in product-margin distribution, recurring sales to hospitals, clinics, and pharmacies, and per-treatment revenue from owned dialysis facilities. Exclusive partnerships with manufacturers such as Rhythm Pharmaceuticals, Oncopeptides, Insmed, and Ayrmid anchor the specialty pharma franchise.

Ariti's go-to-market relies on registered pharmaceutical and medical-device products within the Hellenic National Organization for Medicines (EOF) framework and EOPPY reimbursement system, with the Cyprus market providing geographic diversification. Membership in the Your Products Partners (YPP) international distribution network since 2026 signals continued principal-acquisition momentum. Customer end-markets are hospitals, dialysis patients, and licensed healthcare professionals across both jurisdictions.

Short descriptiontext

Ariti is a Greek pharmaceutical and medical device distributor founded in 1985 that supplies hospitals, clinics, and pharmacies in Greece and Cyprus across oncology, urology, CNS, rare diseases, and medical devices, while also operating 10 private dialysis units.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersAcharnae, Greece
HQ citystring
Acharnae
HQ countrystring
Greece
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical distribution, medical device distribution, dialysis services, nephrology solutions, orphan drug access
Industry2 codes
PRIMARYHLAIACAH
Nephrology & Urology Specialty Pharmaceuticals
SECONDARYHLAIAIAI
Rare Renal & Nephrology Disorder Therapies
Healthcare & Life Sciences/Pharmaceuticals/Orphan & Rare Disease Pharmaceuticals
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code2 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Surgical & Medical Instruments & Apparatus3841
Product category
Pharmaceutical and Medical Device Distribution
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceutical Product Distribution
TypeOne Time License
Description

Distribution and sale of proprietary and licensed pharmaceutical products across oncology, nephrology, urology, CNS, and rare diseases in Greece and Cyprus. Revenue is generated through product sales to hospitals, pharmacies, and healthcare providers. Products include Letrafem (letrozole), Rectoxal (oxaliplatin), Irican (irinotecan), Topocan (topotecan), Gemlag (gemcitabine), Capibine (capecitabine), Sunitinib, and specialty products in urology and CNS categories.

ariti.gr
2Medical Technology / Medical Device Distribution
TypeHardware Sales
Description

Exclusive commercial representation and distribution of internationally recognized medical device brands in Greece. Product categories include hemodialysis machines and consumables, urology catheters (LoFric line), orthopaedic implants (shoulder, knee, hip arthroplasty), surgical products (wound drains, suction tips, hemorrhoid ligators), laboratory refrigerators and freezers, and therapy chairs. Revenue derived from device sales and consumables to hospitals and dialysis clinics.

ariti.gr
3Dialysis Center Services
TypeManaged Services
Description

Operation of a network of 10 Private Dialysis Units (Protypo Nephrology Centers) providing haemodialysis services to renal patients. Centers are located in Athens, Piraeus, Attica, Galatsi, Ilion, Thessaloniki, Pella, Komotini, Patra, and Maniatika Piraeus.

ariti.gr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Ariti S.A. is a Greek pharmaceutical and medical technology distributor that serves as the exclusive commercial representative of international manufacturers in Greece and Cyprus. The company distributes proprietary and licensed pharmaceuticals (oncology, urology, CNS, nephrology, rare diseases) and medical devices (dialysis machines and consumables, urology catheters, orthopedic implants, surgical consumables). In parallel, Ariti operates 10 private hemodialysis units (Protypo Nephrology Centers) across Greece, making it a vertically integrated distributor-and-service-provider.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 10 Private Dialysis Units providing haemodialysis services across Greece
+1 more record
Product overview1 text field

Ariti S.A. is a Greek pharmaceutical and medical technology company founded in 1985, operating through two integrated divisions: MedTech Products (medical devices) and a Pharmaceutical Division. The MedTech division encompasses renal/dialysis products (modern dialysis machines, filters, catheters, fistula needles, CRRT systems, water treatment), urology catheters (LoFric product line, Navina irrigation), orthopedics (shoulder, knee, hip arthroplasty, traumatology), surgery equipment (wound drains, autologous reinfusion, hemorrhoid ligators), and laboratory equipment (refrigerators, freezers, therapy chairs). The pharmaceutical division covers oncology (Letrafem, Rectoxal, Irican, Topocan, Gemlag, Capibine, Sunitinib), urology (Abiraterone, Alfuzin, Lutrak, Solicin, Tamsulosin, Tadalafil), CNS (Quetiapine, Peziled, Escitalopram, Memantine, Prazarit, Rasagiline), nephrology (Reoxyl, Aricitol), small-volume injections, OTC, rare diseases (NTM lung disease with Arikayce), and hematology (Lenalidomide). Ariti also operates dialysis units across Greece and maintains pharmacovigilance and medical device vigilance programs.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
1Your Pharma Partner in Europe (YPP) Network
Strategic tierModerateTypeGTM or Marketing PartnerAnnounced on2026-04-16
Description

Ariti joined the Your Pharma Partner in Europe (YPP) network, an alliance of independent pharmaceutical companies established to support pharmaceutical market access across Europe. This membership strengthens Ariti's strategic presence in the European pharmaceutical sector and expands opportunities for developing new partnerships.

ariti.gr
Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-02-02
Description

Ariti signed an exclusive distribution agreement with Ayrmid (parent company of Gamida Cell Inc.) for the distribution of Omisirge (Omidubicel-onlv) in Greece and Cyprus. Omisirge is a nicotinamide-modified allogeneic hematopoietic bone marrow-derived lineage stem cell therapy.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-12-05
Description

Ariti announced a strategic partnership with Rhythm Pharmaceuticals (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on rare neuroendocrine diseases. Through this collaboration, Ariti spearheads multiple initiatives to raise awareness of rare melanocortin-4 receptor (MC4R) pathway diseases in Greece.

Strategic tierMinorTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-06-18
Description

Oncopeptides AB (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, partnered with Ariti for first named patient sales of Pepaxti (melfalan flufenamide) in Greece. Ariti serves as the local distribution partner enabling access to this orphan oncology drug.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2020-01-01
Description

Ariti and Insmed Ireland Limited signed an agreement for Greece, aiming to increase awareness of non-tuberculosis mycobacteria (NTM) pulmonary disease. This collaboration includes distribution of Arikayce (amikacin liposome inhalation suspension) for NTM lung disease, reinforcing Ariti's rare disease and orphan drug portfolio.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Ariti serves as exclusive commercial representative and distributor for internationally recognized medical technology and pharmaceutical manufacturers. Key brand relationships include LoFric catheters (Wellspect Healthcare/Astra Tech), TauroLock catheter locks (TauroPharma), and various pharmaceutical products from international developers. These partnerships span 35+ years and cover Ariti's entire product portfolio.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Greek pharmaceutical company focused on oncology, supportive care, and specialty therapeutics. Comparable to Ariti's pharma division in product portfolio overlap and Greek market presence.

TypeDirect peer
Description

Greek pharmaceutical company operating across branded generics, consumer health, and medical devices. Comparable to Ariti in being a multi-category Greek healthcare distributor with national reach.

TypeDirect peer
Description

Greek pharmaceutical company specializing in oncology, hematology, and rare diseases with exclusive partnerships with international biotechs. Highly comparable to Ariti's rare disease unit and specialty pharma distribution model.

TypeDirect peer
Description

Greek specialty pharmaceutical company with therapeutic focus areas including oncology, CNS, and rare diseases. Closely comparable to Ariti's pharma division portfolio and distribution approach.

TypeDirect peer
Description

Greek pharmaceutical manufacturer and distributor with broad hospital and retail coverage plus export activity. Comparable to Ariti as a Greek-headquartered pharma company with both manufacturing and distribution capabilities.

TypeDirect peer
Description

Greek pharmaceutical manufacturer and distributor with a broad therapeutic portfolio across multiple specialties. Directly comparable to Ariti as another Greek pharma company with national distribution scale and long operating history.

TypeDirect peer
Description

Greek pharmaceutical company with generics, specialty pharma, and rare disease focus plus international operations. Comparable to Ariti's therapeutic breadth and Greek-based market access capabilities.

TypeBroad incumbent
Description

Italian-headquartered multinational pharmaceutical company with established operations in Greece. Comparable to Ariti in rare disease focus (Recordati Rare Diseases) and Greek market presence, though operating at much larger scale.

TypeBroad incumbent
Description

Global medical device and pharmaceutical company with a major dialysis division and direct Greek operations. Comparable to Ariti's medical device distribution and dialysis-adjacent product portfolio, though as a multinational incumbent.

TypeDirect peer
Description

Greek private dialysis center operator with multiple units. Comparable to Ariti's vertically integrated dialysis center operations, representing direct competition for renal patients and clinical referrals.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ariti

Pharmaceutical and Medical Device Distributionariti.gr

Ariti is a Greek pharmaceutical and medical device distributor founded in 1985 that supplies hospitals, clinics, and pharmacies in Greece and Cyprus across oncology, urology, CNS, rare diseases, and medical devices, while also operating 10 private dialysis units.

What Ariti does

Ariti is a Greek pharmaceutical and medical technology distribution company founded in 1985, headquartered in Greece and operating across both Greece and Cyprus. The company distributes pharmaceuticals across oncology, urology, central nervous system, and rare diseases therapeutic areas, alongside medical devices spanning dialysis machines, catheters, orthopaedic implants, and surgical products. Its core business model rests on long-standing exclusive distribution agreements with international manufacturers, combined with vertical integration into clinical services through 10 private dialysis units across Greece.

The company operates through distinct divisions covering pharmaceuticals, medical devices, and rare diseases, the last of which was established as a dedicated business unit in 2019 to commercialize orphan drugs. Revenue mechanics are anchored in product-margin distribution, recurring sales to hospitals, clinics, and pharmacies, and per-treatment revenue from owned dialysis facilities. Exclusive partnerships with manufacturers such as Rhythm Pharmaceuticals, Oncopeptides, Insmed, and Ayrmid anchor the specialty pharma franchise.

Ariti's go-to-market relies on registered pharmaceutical and medical-device products within the Hellenic National Organization for Medicines (EOF) framework and EOPPY reimbursement system, with the Cyprus market providing geographic diversification. Membership in the Your Products Partners (YPP) international distribution network since 2026 signals continued principal-acquisition momentum. Customer end-markets are hospitals, dialysis patients, and licensed healthcare professionals across both jurisdictions.

Ariti firmographics

Firmographics
Name
Ariti
Legal name
ΑΡΗΤΗ ΑΝΩΝΥΜΗ ΕΤΑΙΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΚΑΙ ΙΑΤΡΙΚΩΝ ΠΡΟΪΟΝΤΩΝ
Website
https://ariti.gr
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
51–100 employees
Short description
Ariti is a Greek pharmaceutical and medical device distributor founded in 1985 that supplies hospitals, clinics, and pharmacies in Greece and Cyprus across oncology, urology, CNS, rare diseases, and medical devices, while also operating 10 private dialysis units.
Ownership category
akta.pro rank

Ariti industry classification

Industry
Product category
Pharmaceutical and Medical Device Distribution
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAIACAH
Nephrology & Urology Specialty Pharmaceuticals
SECONDARYHLAIAIAI
Rare Renal & Nephrology Disorder Therapies
Healthcare & Life Sciences/Pharmaceuticals/Orphan & Rare Disease Pharmaceuticals

Keywords

  • Pharmaceutical distribution
  • Medical device distribution
  • Dialysis services
  • Nephrology solutions
  • Orphan drug access

Where Ariti is headquartered

Location

Headquarters

HQ city
Acharnae
HQ country
Greece
HQ region
Europe

Offices3 records

Markets served

Ariti business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

  1. Pharmaceutical Product Distribution: Distribution and sale of proprietary and licensed pharmaceutical products across oncology, nephrology, urology, CNS, and rare diseases in Greece and Cyprus. Revenue is generated through product sales to hospitals, pharmacies, and healthcare providers. Products include Letrafem (letrozole), Rectoxal (oxaliplatin), Irican (irinotecan), Topocan (topotecan), Gemlag (gemcitabine), Capibine (capecitabine), Sunitinib, and specialty products in urology and CNS categories.
  2. Medical Technology / Medical Device Distribution: Exclusive commercial representation and distribution of internationally recognized medical device brands in Greece. Product categories include hemodialysis machines and consumables, urology catheters (LoFric line), orthopaedic implants (shoulder, knee, hip arthroplasty), surgical products (wound drains, suction tips, hemorrhoid ligators), laboratory refrigerators and freezers, and therapy chairs. Revenue derived from device sales and consumables to hospitals and dialysis clinics.
  3. Dialysis Center Services: Operation of a network of 10 Private Dialysis Units (Protypo Nephrology Centers) providing haemodialysis services to renal patients. Centers are located in Athens, Piraeus, Attica, Galatsi, Ilion, Thessaloniki, Pella, Komotini, Patra, and Maniatika Piraeus.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Ariti product offering

Product offering

Core offering

Ariti S.A. is a Greek pharmaceutical and medical technology distributor that serves as the exclusive commercial representative of international manufacturers in Greece and Cyprus. The company distributes proprietary and licensed pharmaceuticals (oncology, urology, CNS, nephrology, rare diseases) and medical devices (dialysis machines and consumables, urology catheters, orthopedic implants, surgical consumables). In parallel, Ariti operates 10 private hemodialysis units (Protypo Nephrology Centers) across Greece, making it a vertically integrated distributor-and-service-provider.

Product overview

Ariti S.A. is a Greek pharmaceutical and medical technology company founded in 1985, operating through two integrated divisions: MedTech Products (medical devices) and a Pharmaceutical Division. The MedTech division encompasses renal/dialysis products (modern dialysis machines, filters, catheters, fistula needles, CRRT systems, water treatment), urology catheters (LoFric product line, Navina irrigation), orthopedics (shoulder, knee, hip arthroplasty, traumatology), surgery equipment (wound drains, autologous reinfusion, hemorrhoid ligators), and laboratory equipment (refrigerators, freezers, therapy chairs). The pharmaceutical division covers oncology (Letrafem, Rectoxal, Irican, Topocan, Gemlag, Capibine, Sunitinib), urology (Abiraterone, Alfuzin, Lutrak, Solicin, Tamsulosin, Tadalafil), CNS (Quetiapine, Peziled, Escitalopram, Memantine, Prazarit, Rasagiline), nephrology (Reoxyl, Aricitol), small-volume injections, OTC, rare diseases (NTM lung disease with Arikayce), and hematology (Lenalidomide). Ariti also operates dialysis units across Greece and maintains pharmacovigilance and medical device vigilance programs.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 10 Private Dialysis Units providing haemodialysis services across Greece
  • +1 more outcomes

Companies that use Ariti

Customer profile

Named customers3 records

Segments8 records

Ideal customer profiles3 records

Ariti technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Ariti partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered moderate, minor and core.

  • Your Pharma Partner in Europe (YPP) NetworkmoderateGTM or Marketing Partner · 16 April 2026Ariti joined the Your Pharma Partner in Europe (YPP) network, an alliance of independent pharmaceutical companies established to support pharmaceutical market access across Europe. This membership strengthens Ariti's strategic presence in the European pharmaceutical sector and expands opportunities for developing new partnerships.
  • Ayrmid Ltd. / Gamida Cell Inc.minorChannel Partner/ Reseller/ Distributor · 2 February 2026Ariti signed an exclusive distribution agreement with Ayrmid (parent company of Gamida Cell Inc.) for the distribution of Omisirge (Omidubicel-onlv) in Greece and Cyprus. Omisirge is a nicotinamide-modified allogeneic hematopoietic bone marrow-derived lineage stem cell therapy.
  • Rhythm Pharmaceuticals, Inc.coreStrategic or Co-development Partner · 5 December 2024Ariti announced a strategic partnership with Rhythm Pharmaceuticals (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on rare neuroendocrine diseases. Through this collaboration, Ariti spearheads multiple initiatives to raise awareness of rare melanocortin-4 receptor (MC4R) pathway diseases in Greece.
  • Oncopeptides ABminorChannel Partner/ Reseller/ Distributor · 18 June 2023Oncopeptides AB (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, partnered with Ariti for first named patient sales of Pepaxti (melfalan flufenamide) in Greece. Ariti serves as the local distribution partner enabling access to this orphan oncology drug.
  • Insmed Ireland LimitedcoreChannel Partner/ Reseller/ Distributor · 1 January 2020Ariti and Insmed Ireland Limited signed an agreement for Greece, aiming to increase awareness of non-tuberculosis mycobacteria (NTM) pulmonary disease. This collaboration includes distribution of Arikayce (amikacin liposome inhalation suspension) for NTM lung disease, reinforcing Ariti's rare disease and orphan drug portfolio.
  • International Medical Technology and Pharmaceutical ManufacturerscoreChannel Partner/ Reseller/ DistributorAriti serves as exclusive commercial representative and distributor for internationally recognized medical technology and pharmaceutical manufacturers. Key brand relationships include LoFric catheters (Wellspect Healthcare/Astra Tech), TauroLock catheter locks (TauroPharma), and various pharmaceutical products from international developers. These partnerships span 35+ years and cover Ariti's entire product portfolio.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Ariti competitors and assessment

Company assessment

Direct peers

  • Help Pharmaceuticals: Greek pharmaceutical company focused on oncology, supportive care, and specialty therapeutics. Comparable to Ariti's pharma division in product portfolio overlap and Greek market presence.
  • Galenica: Greek pharmaceutical company operating across branded generics, consumer health, and medical devices. Comparable to Ariti in being a multi-category Greek healthcare distributor with national reach.
  • Genesis Pharma: Greek pharmaceutical company specializing in oncology, hematology, and rare diseases with exclusive partnerships with international biotechs. Highly comparable to Ariti's rare disease unit and specialty pharma distribution model.
  • Win Medica: Greek specialty pharmaceutical company with therapeutic focus areas including oncology, CNS, and rare diseases. Closely comparable to Ariti's pharma division portfolio and distribution approach.
  • DEMO SA: Greek pharmaceutical manufacturer and distributor with broad hospital and retail coverage plus export activity. Comparable to Ariti as a Greek-headquartered pharma company with both manufacturing and distribution capabilities.
  • Elpen Pharmaceutical: Greek pharmaceutical manufacturer and distributor with a broad therapeutic portfolio across multiple specialties. Directly comparable to Ariti as another Greek pharma company with national distribution scale and long operating history.
  • Pharmathen: Greek pharmaceutical company with generics, specialty pharma, and rare disease focus plus international operations. Comparable to Ariti's therapeutic breadth and Greek-based market access capabilities.
  • Mesogeios Dialysis Centers: Greek private dialysis center operator with multiple units. Comparable to Ariti's vertically integrated dialysis center operations, representing direct competition for renal patients and clinical referrals.

Broad incumbents

  • Recordati: Italian-headquartered multinational pharmaceutical company with established operations in Greece. Comparable to Ariti in rare disease focus (Recordati Rare Diseases) and Greek market presence, though operating at much larger scale.
  • B. Braun: Global medical device and pharmaceutical company with a major dialysis division and direct Greek operations. Comparable to Ariti's medical device distribution and dialysis-adjacent product portfolio, though as a multinational incumbent.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Ariti social profiles

Digital presence

Ariti compliance and trust

Trust signal

Compliance1 record

Ariti financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ariti leadership team

Management profile

Number of profiles

Ariti funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ariti M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ariti

What does Ariti do?

Ariti S.A. is a Greek pharmaceutical and medical technology distributor that serves as the exclusive commercial representative of international manufacturers in Greece and Cyprus. The company distributes proprietary and licensed pharmaceuticals (oncology, urology, CNS, nephrology, rare diseases) and medical devices (dialysis machines and consumables, urology catheters, orthopedic implants, surgical consumables). In parallel, Ariti operates 10 private hemodialysis units (Protypo Nephrology Centers) across Greece, making it a vertically integrated distributor-and-service-provider.

Is Ariti a public or private company?

Ariti is a private company. It is classified as unknown and is currently operating.

When was Ariti founded?

Ariti was founded in 1985. It employs 51 to 100 people.

Where is Ariti based?

Ariti is headquartered in Acharnae, Greece, in the Europe region.

How does Ariti make money?

Three revenue lines are on record. Pharmaceutical Product Distribution is the primary driver. The others are medical Technology / Medical Device Distribution and dialysis Center Services.

Who are Ariti's main competitors?

Direct peers on record are Help Pharmaceuticals, Galenica, Genesis Pharma, Win Medica, DEMO SA, Elpen Pharmaceutical, Pharmathen and Mesogeios Dialysis Centers. Broad incumbents are Recordati and B. Braun.

Does Ariti have an API?

No public API is recorded for Ariti.

What industry is Ariti in?

Ariti's product category is Pharmaceutical and Medical Device Distribution. Its primary akta.pro industry code is HLAIACAH, Nephrology & Urology Specialty Pharmaceuticals, with a secondary code of HLAIAIAI, Rare Renal & Nephrology Disorder Therapies. Its NAICS code is 42421 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals